Home › Stocks › ARCT

Arcturus Therapeutics Holdings Inc. (ARCT): insider buying, hedge funds & Congress trades

Arcturus Therapeutics Holdings Inc. (ARCT): 1 insider purchase in the last two years.

Insider buying

FiledInsiderSharesPriceValueType
Aug 20, 2025Sassine Andy
Director, Officer
1,238$16.56$20.5Kno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for ARCT

Free account. Know when insiders, famous funds or Congress trade it.

Start free